4D Molecular Therapeutics
FDMT
FDMT
63 hedge funds and large institutions have $515M invested in 4D Molecular Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8.89% more ownership
Funds ownership: 62.1% → 71% (+8.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
63
Holding in Top 10
2
Calls
–
Puts
$2K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$12.8M | |
| 3 | +$7.22M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.85M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.71M |
Top Sellers
| 1 | -$5.31M | |
| 2 | -$1.68M | |
| 3 | -$901K | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$713K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$502K |